Successful use of inhaled form of Fluimucil-antibiotic IT in the complex therapy of respiratory infectious and inflammatory diseases
- Autores: Ovcharenko S1, Kapustina V1, Son E1, Ovcharenko S.I.1, Kapustina V.A.1, Son E.A.1
-
Afiliações:
- Edição: Nº 11 (2010)
- Páginas: 42-45
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278468
- ID: 278468
Citar
Texto integral
Resumo
The use of combined drug - thiamphenicol glycinate acetylcysteinate (TGA), consisting of the universal mucolytic (N-acetylcysteine) and broad-spectrum antibiotic (thiamphenicol) at a dose of 500 mg in infectious-inflammatory diseases of the respiratory system is justified. Outlined case history of the use of TGA in the treatment of exacerbation of bronchiectatic disease demonstrated high therapeutic efficacy of the drug. The advantages of nebulizer route of administration of TGA is emphasized.
Bibliografia
- Costerton JW, et al. Scientific American. 1978;238:86.
- El-Azizi M, Rao S, Kanchanapoom T, et al. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 2005;4:2.
- Riise GC, Larsson S, Jeansson S, et al. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J 1994;7:94-101.
- Zheng CH, Ahmed K, Rikitomi N, et al. The effects of S-carboxymethylcysteine and N-acetylcysteine on the adherence of Moraxella catarrhalis to human pharyngeal epithelial cells. Microbiol Immunol 1999;43(2):107-13.
- Albini E, Belluco G, Berton M, et al. In vitro antibacterial activity of thiamphenicol glycinate acetylcysteinate against respiratory pathogens. Arzneim-Forsch Drug Res 1999;49:533-35.
- Rizzato G. Antibiotics for aerosol intake in respiratory infections: pole position for tiamfenicol. L'Internista J 2001;9:120.
- Lombardi A, Drago L, De Vecchi E, et al. Antimicrobial activity of thiamphenicol-glycinate-acetylcysteinate and other drugs against Chlamydia pneumoniae. Arzneimittelforschung. 2001;51(3):264-67.
- Drago L, Fassina MC, Mombelli B, et al. Comparative effect of thiamphenicol glycinate, thiamphenicol glycinate N-acetylcysteinate, amoxicillin plus clavulanic acid, ceftriaxone and clarithromycin on pulmonary clearance of Haemophilus influenzae in an animal model. Chemotherapy 2000;46(4):275-81.
- Овчаренко C.И., Морозова Н.В. Эффективность применения Флуимуцил-антибиотика ИТ в лечении обострений ХОБЛ // Атмосфера. Пульмонология и аллергология. 2003. № 3. С. 26-28.
Arquivos suplementares
